Cafepharma Today

March 10 2025 - On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Novo Nordisk's Ozempic successor disappointed Wall Street again
AstraZeneca reports positive outcomes from trial of Imfinzi
The evolution of medical sales: what’s changing in 2025?
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Theravance antibiotic wins FDA panel OK
Bizjournals.com
Thursday, November 20, 2008 - 7:52am
tags:
Pfizer Pulls EU Request for Over-the-Counter Viagra
Bloomberg
Thursday, November 20, 2008 - 7:49am
tags:
Amgen, Takeda's Drug for Lung Cancer Suspended After Deaths
Bloomberg
Thursday, November 20, 2008 - 7:36am
tags:
Novartis: New research strategies paying off
Yahoo/AP
Wednesday, November 19, 2008 - 10:46am
tags:
Amid Big Pharma Woes, Shire in “Best Shape Ever”
PharmExec
Wednesday, November 19, 2008 - 10:22am
tags:
FDA 'black box' warning advised for cancer drug Avastin
USA Today
Wednesday, November 19, 2008 - 10:14am
tags:
Novo Nordisk: Approval of New Diabetes Drug Is Further Postponed
Seeking Alpha
Wednesday, November 19, 2008 - 10:12am
tags:
Teva gets FDA approval for generic asthma drug
Yahoo/AP
Wednesday, November 19, 2008 - 10:06am
tags:
FTC To Hold Roundtable On Follow-On Biologics
Pharmalot
Wednesday, November 19, 2008 - 10:03am
tags:
AstraZeneca: FDA Agrees with Some Pulmicort Concerns
Easy Bourse, France
Wednesday, November 19, 2008 - 10:02am
tags:
Elan seeks deals to raise cash
Reuters
Wednesday, November 19, 2008 - 10:00am
tags:
A Heavy Heart: The FDA Weighs CV Side Effects
Pharmalot
Wednesday, November 19, 2008 - 9:58am
tags:
More Pressure to Curb Antipsychotic Use in Kids
WSJ Online
Wednesday, November 19, 2008 - 9:51am
tags:
Big Pharma Steps Up China Investment
Seeking Alpha
Wednesday, November 19, 2008 - 9:51am
tags:
Glaxo rejected Maryland doctor's Avandia warning: report
Marketwatch
Wednesday, November 19, 2008 - 9:49am
tags:
Sanofi Settles Allergy Drugs Dispute With Barr, Teva
Bloomberg
Wednesday, November 19, 2008 - 9:48am
tags:
Novartis to Combine Heart Pills as Afinitor Cancer Drug Delayed
Bloomberg
Wednesday, November 19, 2008 - 9:46am
tags:
Are Costly Diabetes Pills Doing Any Good?
Pharmalot
Wednesday, November 19, 2008 - 2:02am
tags:
Pfizer And Wyeth Sued By Nevada Attorney General
Pharmalot
Wednesday, November 19, 2008 - 1:57am
tags:
Eli Lilly sues 4 generic drugmakers to protect the patent guarding lucrative Cymbalta
Yahoo/AP
Wednesday, November 19, 2008 - 1:52am
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Bridging the Gap in Patient Support: How GoodRx is Revolutionizing Access to Specialty Meds
Drug Channels
Bird is the (Geomagnetic) Word
In the Pipeline
The Continuing Crisis, Part VII: An Overview
In the Pipeline
Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws
Drug Channels
The Continuing Crisis, Part VI: Rare Diseases at the FDA and More
In the Pipeline
PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)
Drug Channels
Progress on RNA-Based Cancer Vaccines
In the Pipeline
Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information